All In MedTech

FDA Clearance Tracker · P160030-S042

Freestyle Libre 14 day Flash Glucose Monitoring System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 21, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 21, 2020

Approved

Time to decision

50 days

Received Apr 1, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P160030-S042
Device name
Freestyle Libre 14 day Flash Glucose Monitoring System
Applicant location
Alameda, CA
Received
Apr 1, 2020
Decided
May 21, 2020
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P160030

Device type

Device class
Class III

Every decision under product code PZE

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Tech Group Europe Limited t/a West, Damastown Close, Damastown Industrial Park, Mulhuddart, Dublin 15, D15 K009 Ireland for sensor kit assembly. The sensor kit is a component of the Freestyle Libre 14 day Flash Glucose Monitoring System.

Source documents

Other decisions for Abbott Diabetes Care, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.